BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28476858)

  • 1. Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.
    Allan CM; Jung CJ; Larsson M; Heizer PJ; Tu Y; Sandoval NP; Dang TLP; Jung RS; Beigneux AP; de Jong PJ; Fong LG; Young SG
    J Lipid Res; 2017 Jul; 58(7):1453-1461. PubMed ID: 28476858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
    Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
    Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
    Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
    J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.
    Beigneux AP; Gin P; Davies BS; Weinstein MM; Bensadoun A; Fong LG; Young SG
    J Biol Chem; 2009 Oct; 284(44):30240-7. PubMed ID: 19726683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
    Olivecrona G; Ehrenborg E; Semb H; Makoveichuk E; Lindberg A; Hayden MR; Gin P; Davies BS; Weinstein MM; Fong LG; Beigneux AP; Young SG; Olivecrona T; Hernell O
    J Lipid Res; 2010 Jun; 51(6):1535-45. PubMed ID: 20026666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
    Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
    Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
    Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase.
    Beigneux AP; Davies BS; Tat S; Chen J; Gin P; Voss CV; Weinstein MM; Bensadoun A; Pullinger CR; Fong LG; Young SG
    J Biol Chem; 2011 Jun; 286(22):19735-43. PubMed ID: 21478160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
    Gin P; Beigneux AP; Voss C; Davies BS; Beckstead JA; Ryan RO; Bensadoun A; Fong LG; Young SG
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):176-82. PubMed ID: 20966398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
    Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
    J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.
    Allan CM; Larsson M; Hu X; He C; Jung RS; Mapar A; Voss C; Miyashita K; Machida T; Murakami M; Nakajima K; Bensadoun A; Ploug M; Fong LG; Young SG; Beigneux AP
    J Lipid Res; 2016 Oct; 57(10):1889-1898. PubMed ID: 27494936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
    Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter.
    Turlo K; Leung CS; Seo JJ; Goulbourne CN; Adeyo O; Gin P; Voss C; Bensadoun A; Fong LG; Young SG; Beigneux AP
    Biochim Biophys Acta; 2014 Jul; 1841(7):963-9. PubMed ID: 24704550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries.
    Allan CM; Larsson M; Jung RS; Ploug M; Bensadoun A; Beigneux AP; Fong LG; Young SG
    J Lipid Res; 2017 Jan; 58(1):216-225. PubMed ID: 27811232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.
    Beigneux AP; Davies BS; Gin P; Weinstein MM; Farber E; Qiao X; Peale F; Bunting S; Walzem RL; Wong JS; Blaner WS; Ding ZM; Melford K; Wongsiriroj N; Shu X; de Sauvage F; Ryan RO; Fong LG; Bensadoun A; Young SG
    Cell Metab; 2007 Apr; 5(4):279-91. PubMed ID: 17403372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPIHBP1 and Plasma Triglyceride Metabolism.
    Fong LG; Young SG; Beigneux AP; Bensadoun A; Oberer M; Jiang H; Ploug M
    Trends Endocrinol Metab; 2016 Jul; 27(7):455-469. PubMed ID: 27185325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
    Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
    J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase.
    Beigneux AP; Gin P; Davies BS; Weinstein MM; Bensadoun A; Ryan RO; Fong LG; Young SG
    J Lipid Res; 2008 Jun; 49(6):1312-21. PubMed ID: 18340083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPIHBP1 and lipolysis: an update.
    Beigneux AP; Weinstein MM; Davies BS; Gin P; Bensadoun A; Fong LG; Young SG
    Curr Opin Lipidol; 2009 Jun; 20(3):211-6. PubMed ID: 19369870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
    Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.